A Glance of Global Cardiovascular Therapeutic Drugs Market Trends

Cardiovascular Therapeutic Drugs – A Historical Perspective

Cardiovascular Therapeutic Drugs are those prescription medicines and drugs that are used or prescribed for the treatment of cardiovascular diseases. More than 58 million people die globally due to various diseases with cardiovascular diseases accounting for 30% of the total deaths. About half of the people dying from non-communicable diseases were due to cardiovascular diseases and the risk of death is higher for people aged 70 years and above. Therefore, the role of cardiovascular therapeutic drugs in preventing these deaths is quite significant.

The origins of cardiovascular therapeutic drugs began during early 19th and 20th centuries when natural products extracts especially those derived from botanical species provided the main source of folk medicines. In the latter part of the 19th century, biologically active organic molecules began to be isolated in relatively pure form for medicinal use.

For instance, salicylic acid, precursor of aspirin was isolated in 1874 from willow bark. The leaves of purple foxglove plant provided an excellent source of digitalis that was purified for use against cardiovascular diseases. Over the years, the cardiovascular therapeutic drugs such as Aspirin that is most widely used and tested anti platelet drug in cardiovascular disease (CVD) has emerged as one of the highly effective drug for cardiovascular disease.

 Cardiovascular Therapeutic Drugs Market growth – An analysis

Overall, the global cardiovascular therapeutics drugs market value is currently worth US $126.8 billion in 2016 that is projected to reach US $141.38 billion by the end of 2021 with a CAGR of 2.2%. The cardiovascular therapeutic drugs market growth is witnessing a sustained modest growth during the past five years with the same trends remaining to continue over the next five years. The global cardiovascular market registered sales of $170 billion during 2010. The rise in cardiovascular diseases across the global population is creating a demand for cardiovascular therapeutic drugs that are helpful in the treatment in the form of enhancing the pumping capacity of the heart or in increasing the supply of oxygen to the heart. CVD remains the most common cause of mortality and morbidity in the world and is an emerging threat. The key drivers or factors that are helping towards the cardiovascular therapeutic drugs market growth as per a leading cardiovascular Therapeutic Drugs Market Report include-

  • Aging Population
  • Growth in the per capita medical spending in developed and developing economies
  • General medical problems such as diabetes, obesity and hypertension etc
  • Presence of higher number of innovative drugs under the clinical studies

According to the Centers for Disease Control and Prevention (CDC) every year about 610,000 people in United States of America die of heart disease thereby creating a surge in demand for cardiovascular drugs.

Download free sample report: http://www.marketdataforecast.com/market-reports/global-cardiovascular-therapeutic-drugs-market-1426/request-sample

Cardiovascular Therapeutic Drugs Market Size – A Diagrammatic View

The global cardiovascular drugs market is segmented based on drugs such as anti-hypertensive drugs, anti-dyslipidemics drugs and anti-thrombotic drugs out of which antihypertensive drugs accounts for 22% Cardiovascular Therapeutic Drugs Market share with a total sales of about $37.7 billion. Anti-thrombotic drugs accounted for about 11% of total sales in 2010 with revenues of about $18.7 billion. The sales of major drug classes are shown in tabulated format with numbers that does not include the pipeline drugs that are likely to be approved over the forecast period is depicted as shown below

Drug Class 2010 2011 2012 2013 2014 2015 2016 CAGR
Antihypertensive 37,657 36,392 34307 30,791 29,637 29,283 28,413 -4.6
Antidyslipidemic 29,899 29,822 25,230 24,744 24,459 23,828 20,156 -6.4
Antithrombotic 18,687 18,185 14,403 13,030 14,294 15,360 16,126 -2.4
Others 84,213 89,306 95,240 1,01544 108238 115199 122206 6.4
Total 170460 173706 169179 170109 176629 183671 186901 1.6

Table: 1-Global Market Size of Major Cardiovascular Drug Classes ($m) – 2010-16

Source:   Company Reported Sales – Business Insights

Inquire before buying :  http://www.marketdataforecast.com/market-reports/global-cardiovascular-therapeutic-drugs-market-1426/inquire

The cardiovascular drug market is expected to demonstrate healthy growth rate as observed from the above-mentioned table with a CAGR of 1.6. The cardiovascular drug delivery market in addition to usually formulation drugs consists of devices as well such as drug-eluting stents, pacemakers, balloons and other devices. The major key players or companies doing business in global cardiovascular drug market include

  • Novartis
  • AG Forest laboratories Inc
  • BayerAG
  • GlaxoSmithKline plc
  • Daiichi Sankyo Co. Ltd
  • Pfizer Inc
  • Solvay SA
  • Sanofi
  • Johnson & Johnson

In the coming decades, the global cardiovascular therapeutics drug market is anticipated to witness a significant growth.

Visit here for more reportshttp://www.marketdataforecast.com

Share this post:

Recent Posts

Leave a Comment

6 + 2 =